Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. A 'Back to Top' navigation element was removed, a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T19:14:46.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T15:37:55.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include specific drug information for Tislelizumab and detailed location data for facilities in Beijing and Shanghai, while removing some redundant location terms and previous versions of the drug information.
    Difference
    4%
    Check dated 2025-08-31T12:00:22.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:36:07.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:27:42.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-01T18:49:44.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.